The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis
Open accessAbstract
The relationship between the expression levels of matrix metalloproteinase-2 (MMP-2) and MMP-9 and breast cancer prognosis was studied. Two breast cancer cell lines (MDA-MB-231 and MCF-7) and one human normal breast cell line (HS578Bst) were investigated. Fluorescence real-time reverse transcription-polymerase chain reaction (RT-PCR) and western blotting were used to detect cellular mRNA and protein MMP-2 and MMP-9 expression levels. Breast cancer tissue samples from 80 patients and tumor-adjacent normal tissue samples from 40 patients were collected, and MMP-2 and MMP-9 expression in these samples were examined using immunohistochemistry (IHC). The relationship of MMP-2 and MMP-9 expression levels with breast cancer patient clinicopathological parameters and prognosis was analyzed. RT-PCR and western blot results showed that MMP-2 and MMP-9 mRNA and protein expression levels were significantly higher in MDA-MB-231 and MCF-7 cells than in HS578Bst cells. A high expression of MMP-2 and MMP-9 was found in 83.75% (67/80) and 78.75% (63/80) of breast cancer tissue samples, respectively. MMP-2 and MMP-9 expression in breast cancer tissues were significantly different from that in tumor-adjacent normal tissues (p<0.01). MMP-2 and MMP-9 expression levels in breast cancer tissues were correlated with lymph node metastasis and tumor staging. Single factor survival analysis showed that MMP-2 and MMP-9 were factors influencing breast cancer prognosis. MMP-2 and MMP-9 are highly expressed in breast cancer tissues and are closely related to lymph node metastasis and tumor staging. MMP-2 and MMP-9 can be used as reference indices for guiding breast cancer prognosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Stoeltzing, O., Ahmad, S. A., Liu, W., McCarty, M. F., Wey, J. S., Parikh, A. A., Fan, F., Reinmuth, N., Kawaguchi, M., Bucana, C. D., et al. (2003) · PubMed · Cited by 188
Jones, J. L., Glynn, P., & Walker, R. A. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199910)189:2<161::aid-path406>3.0.co;2-2 · Cited by 183
Li, H.-C., Cao, D.-C., Liu, Y., Hou, Y.-F., Wu, J., Lu, J.-S., Di, G.-H., Liu, G., Li, F.-M., Ou, Z.-L., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-1200-8 · Cited by 181
Self-citationZhou, R., Xu, L., Ye, M., Liao, M., Du, H., & Chen, H. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1376977 · Cited by 179
Fernández‐García, B., Eiró, N., Marín, L., González‐Reyes, S., González, L. O., Lamelas, M. L., & Vizoso, F. J. (2013) · Histopathology · doi:10.1111/his.12300 · Cited by 159
Li, H., Huang, J., Yang, B. L., Xiang, T., Yin, X., Peng, W., Cheng, W., Wan, J., Luo, F., Li, H., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.011 · Cited by 107
Self-citationZhang, W., Wang, F., Xu, P., Miao, C., Zeng, X., Cui, X., Lu, C., Xie, H., Yin, H. X., Chen, F., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.06.004 · Cited by 57
Choi, J. S., Baek, H., Kim, S., Kim, M. J., Youk, J. H., Moon, H. J., Kim, E., & Nam, Y. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083866 · Cited by 43
Cited by
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Huang, H. (2018) · Sensors · doi:10.3390/s18103249 · Cited by 739
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Tumor-Associated Neutrophils in Cancer: Going Pro
Wu, L., Saxena, S., Awaji, M., & Singh, R. K. (2019) · Cancers · doi:10.3390/cancers11040564 · Cited by 337
Jiang, H., & Li, H. (2021) · BMC Cancer · doi:10.1186/s12885-021-07860-2 · Cited by 261
Self-citation
Metadata
- Authors
- Li, H., Qiu, Z., Li, F., & Wang, C.
- Venue
- Oncology Letters
- Publisher
- Spandidos Publications
- Published
- 2017-09-13
- Volume
- 14
- Issue
- 5
- Pages
- 5865-5870
- ISSN
- 1792-1074 (ISSN-L)
- 1792-1082
- OpenAlex
- W2754516505
- Cited by
- 290
- References
- 15
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. https://app.cochat.ai/papers/10.3892/ol.2017.6924
- The paper
- Li, H., Qiu, Z., Li, F., & Wang, C. (2017). The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncology Letters. https://doi.org/10.3892/ol.2017.6924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.